SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · Seven executives at Teva Pharmaceutical exercised stock derivatives and…

TEVA PHARMACEUTICAL INDUSTRIES LTD · CLUSTER filed Feb 25, 2026 at 19:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Feb 25, 2026 at 19:00 ET

Seven executives at Teva Pharmaceutical exercised stock derivatives and several conducted open-market sales totaling approximately $2.13 million in the past week. The transactions are primarily non-cash exercises, but significant insider selling by multiple C-suite executives suggests profit-taking at current price levels.

  • Multiple C-suite executives sold shares in open-market transactions on 2026-03-05.
  • Total open-market sales amounted to $2,132,043 across five insiders.
  • All sales occurred at $31.6684 per share, indicating coordinated timing.
  • Selling executives include EVPs of Global Operations, Europe Commercial, U.S. Commercial, Interim Chief Legal Officer, and others.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access